1-3 of 3
Robert B. Geller
Close
Sort by
Journal Articles

A Phase I Study of Cloretazine® and Temozolomide in Patients with Hematologic Malignancies.

David A. Rizzieri, William Tse, Khuda D. Khan, Anjali Advani, Jon Donze, Verena Karsten, Robert B. Geller, Stanton L. Gerson
Journal: Blood
Blood (2006) 108 (11): 1971.
https://doi.org/10.1182/blood.V108.11.1971.1971
Published: 2006
Journal Articles

Effect of postremission chemotherapy before human leukocyte antigen–identical sibling transplantation for acute myelogenous leukemia in first complete remission

Clinical Trials & Observations
Martin S. Tallman, Philip A. Rowlings, Gustavo Milone, Mei-Jie Zhang, Waleska S. Perez, Daniel Weisdorf, Armand Keating, Robert Peter Gale, Robert B. Geller, Mary J. Laughlin, Hillard M. Lazarus, Selina M. Luger, Philip L. McCarthy, Jacob M. Rowe, Ruben A. Saez, Marcus R. Vowels, Mary M. Horowitz
Journal: Blood
Blood (2000) 96 (4): 1254–1258.
https://doi.org/10.1182/blood.V96.4.1254
Published: 2000
Journal Articles

A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation

Michael R. Bishop, Stefano R. Tarantolo, Robert B. Geller, James C. Lynch, Philip J. Bierman, Z. Steven Pavletic, Julie M. Vose, Susan Kruse, Suzanne P. Dix, Mary E. Morris, James O. Armitage, Anne Kessinger
Journal: Blood
Blood (2000) 96 (1): 80–85.
https://doi.org/10.1182/blood.V96.1.80
Published: 2000